Patient Perspectives: The Effects of Contemporary Phosphorus Management on Quality of Life
Effective regulation of phosphate levels is essential for managing the health of the nearly 600,000 dialysis patients in the United States, over 43% of whom exceed the recommended serum phosphate target of 5.5 mg/dL. Current phosphate binders present significant challenges, including large pills that are hard to swallow, pills that require thorough chewing, which may be difficult for patients with impaired dentition, frequent dosing, gastrointestinal adverse effects, and the need to take them while in public, which can lead to non-adherence and reduced social eating. Coupled with stringent dietary restrictions, confusion over administration timing, and high medication cost, these factors severely compromise patients’ quality of life. Addressing these barriers requires a comprehensive strategy: clinicians must recognize the difficulties faced by patients, bridge knowledge gaps regarding dietary phosphorus, and explore novel therapies that reduce pill size and burden without sacrificing efficacy. By mitigating these challenges, healthcare providers can enhance treatment experiences, strengthen patient-clinician relationships, and ultimately improve overall quality of life for dialysis patients. With a focus on patients’ perspectives, this review highlights the critical need for patient-centered approaches in phosphate management to ensure better clinical outcomes and patient satisfaction.
DOI: 10.29245/2767-5149/2024/1.1121 View / Download Pdf